Assessing cancer clinical trials: Will your patient benefit from a 'breakthrough'?

Maurie Markman, MD
Chairman, Taussig Cancer Center and Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Maurie Markman, MD, Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; email markmam@ccf.org

Maurie Markman, MD
Chairman, Taussig Cancer Center and Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Maurie Markman, MD, Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; email markmam@ccf.org

Maurie Markman, MD
Chairman, Taussig Cancer Center and Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Maurie Markman, MD, Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; email markmam@ccf.org